What is High-Throughput Screening (HTS) Market?
The high-throughput screening method is used for scientific experimentation in drug discovery and in the fields of biology and chemistry. It allows a researcher to quickly conduct millions of chemical, genetic, or pharmacological tests, using data processing software, liquid handling devices, robotics, and sensitive detectors. The results of these experiments provide starting points for drug design and for understanding the noninteraction or role of a particular location.
The market study is being classified by Type (Instruments, Consumables, Software and Service), by Application (Drug Discovery, Biochemical Screening, Research and Others) and major geographies with country level break-up.
Thermo Fisher Scientific, Inc. (United States), Agilent Technologies, Inc. (United States), Danaher Corporation (United States), PerkinElmer, Inc. (United States), Promega Corporation (United States), Bio-Rad Laboratories, Inc. (United States), Promega Corporation (United States), Hamilton Company (United States), Corning Incorporated (United States) and Charles River Laboratories (United States) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Creative Biolabs (United States), BPS Bioscience, Inc. (United States), Albany Molecular Research Inc. (United States), Tecan Group Ltd. (Switzerland) and Merck KGaA (Germany).
The United States High-Throughput Screening (HTS) market is very fragmented due to the presence of major players. Moreover, major companies in the market are involved in strategic acquisitions, collaborations, and mergers to sustain their position in the market. Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global High-Throughput Screening (HTS) market throughout the predicted period.
Analyst at AMA have segmented the market study of Global High-Throughput Screening (HTS) market by Type, Application and Region.
On the basis of geography, the market of High-Throughput Screening (HTS) has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
- Rising Number of Drug Targets for Screening, And Growing Adoption of Open Innovation Models in Pharmaceutical & Biotechnology Companies
- Growing Investments by Government and Research Institutes
- Rising Prevalence of Diseases among People
- Complexities in Assay Development and Capital-Intensive Nature of HTS Instruments
- Technological Advancements and Increasing Pharmaceutical R&D Expenditure
- Growing Applications in Stem Cell Research
- Lack of Skilled Professional to Operate the Software’s and Instruments
Market Leaders and some development strategies
In 2020, Danaher Corporation has acquired the biopharma business of General Electric Company to expand its presence in the high-throughput screening market. and In 2019, Agilent Technologies, Inc. has acquired BioTek Instruments to expand its presence and expertise in cell analysis. This development also strengthened the firm’s position in the expansive immune-oncology and immunotherapy areas.
Key Target AudienceHigh-Throughput Screening (HTS) Service Providers, Software Developers/Vendors, Healthcare and Research Institutes, Pharmaceutical Companies, End-Use Industries and Others
Customization in the Report Available:The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase